Cargando…

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances

Detalles Bibliográficos
Autores principales: Aguilar, Gerardo, Ferriols, Rafael, Martínez-Castro, Sara, Ezquer, Carlos, Pastor, Ernesto, Carbonell, Jose A., Alós, Manuel, Navarro, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954510/
https://www.ncbi.nlm.nih.gov/pubmed/31924240
http://dx.doi.org/10.1186/s13054-019-2724-y
_version_ 1783486807998988288
author Aguilar, Gerardo
Ferriols, Rafael
Martínez-Castro, Sara
Ezquer, Carlos
Pastor, Ernesto
Carbonell, Jose A.
Alós, Manuel
Navarro, David
author_facet Aguilar, Gerardo
Ferriols, Rafael
Martínez-Castro, Sara
Ezquer, Carlos
Pastor, Ernesto
Carbonell, Jose A.
Alós, Manuel
Navarro, David
author_sort Aguilar, Gerardo
collection PubMed
description
format Online
Article
Text
id pubmed-6954510
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69545102020-01-14 Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, Jose A. Alós, Manuel Navarro, David Crit Care Letter BioMed Central 2020-01-10 /pmc/articles/PMC6954510/ /pubmed/31924240 http://dx.doi.org/10.1186/s13054-019-2724-y Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Aguilar, Gerardo
Ferriols, Rafael
Martínez-Castro, Sara
Ezquer, Carlos
Pastor, Ernesto
Carbonell, Jose A.
Alós, Manuel
Navarro, David
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
title Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
title_full Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
title_fullStr Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
title_full_unstemmed Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
title_short Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
title_sort optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954510/
https://www.ncbi.nlm.nih.gov/pubmed/31924240
http://dx.doi.org/10.1186/s13054-019-2724-y
work_keys_str_mv AT aguilargerardo optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT ferriolsrafael optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT martinezcastrosara optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT ezquercarlos optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT pastorernesto optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT carbonelljosea optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT alosmanuel optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances
AT navarrodavid optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapysomenuances